Lilly signs $1.3 billion deal with Superluminal to discover obesity medicines using AI - Reuters

Reuters | Aug. 14, 2025, 1:30 p.m. | Original
Lilly signs $1.3 billion deal with Superluminal to discover obesity medicines using AI Reuters
Deere warns of bigger tariff hit after quarterly profit declines - Reuters Exclusive: HSBC plans major global expansion of office, staff surveillance, documents show - Reuters